JAMES B. BREITMEYER

Insider Reports History

Signature
/s/Chase C. Leavitt, Attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by JAMES B. BREITMEYER:

Company Role Class Num Shares Value Price $ Report Date Ownership
Oncternal Therapeutics, Inc. Chief Executive Officer, Director Common Stock 443,034 $219,789 $0.4961 03 Jan 2024 Direct
Oncternal Therapeutics, Inc. Chief Executive Officer, Director Common Stock 196,544 $97,505 $0.4961 03 Jan 2024 By Family Trust
Oncternal Therapeutics, Inc. Chief Executive Officer, Director Common Stock 15,426 $7,653 $0.4961 03 Jan 2024 By Spouse
Oncternal Therapeutics, Inc. Chief Executive Officer, Director Common Stock 733 $364 $0.4961 03 Jan 2024 By Child
Oncternal Therapeutics, Inc. Chief Executive Officer, Director Stock Option 28,400 14 Feb 2024 Direct
OTONOMY, INC. Director Stock Option (right to buy) 27,500 21 Jun 2022 Direct
Oncternal Therapeutics, Inc. Chief Executive Officer, Director Stock Option 6,200 14 Feb 2024 By Spouse
ZOGENIX, INC. Director Common Stock 0 $26.04 07 Mar 2022 Direct
ZOGENIX, INC. Director Stock Option (Right to Buy) 0 $26.09 07 Mar 2022 Direct

Insider Reports Filed by JAMES B. BREITMEYER

Symbol Company Period Transactions Value $ Form Type Role Filing Time
/report/000120919124003413-breitmeyer-james-b-2024-02-14 Oncternal Therapeutics, Inc. 14 Feb 2024 2 $0 4 Chief Executive Officer, Director 15 Feb 2024, 18:00
/report/000120919124000970-breitmeyer-james-b-2024-01-03 Oncternal Therapeutics, Inc. 03 Jan 2024 2 -$27,504 4 Chief Executive Officer, Director 05 Jan 2024, 16:00
/report/000120919123052019-breitmeyer-james-b-2023-10-02 Oncternal Therapeutics, Inc. 02 Oct 2023 24 $0 4 Chief Executive Officer, Director 04 Oct 2023, 17:00
/report/000120919123041319-breitmeyer-james-b-2023-07-03 Oncternal Therapeutics, Inc. 03 Jul 2023 2 -$18,720 4 Chief Executive Officer, Director 05 Jul 2023, 18:59
/report/000120919123024390-breitmeyer-james-b-2023-04-13 Oncternal Therapeutics, Inc. 13 Apr 2023 3 +$43,930 4 Chief Executive Officer, Director 17 Apr 2023, 06:00
/report/000120919123012657-breitmeyer-james-b-2023-02-21 Oncternal Therapeutics, Inc. 21 Feb 2023 3 $0 4 Chief Executive Officer, Director 24 Feb 2023, 15:00
/report/000120919123002033-breitmeyer-james-b-2023-01-03 Oncternal Therapeutics, Inc. 03 Jan 2023 2 -$29,700 4 Chief Executive Officer, Director 05 Jan 2023, 17:00
/report/000120919122043735-breitmeyer-james-b-2022-07-28 Oncternal Therapeutics, Inc. 28 Jul 2022 4 $0 4 Chief Executive Officer, Director 01 Aug 2022, 18:18
/report/000120919122038881-breitmeyer-james-b-2022-06-21 OTONOMY, INC. 21 Jun 2022 1 $0 4 Director 23 Jun 2022, 16:30
/report/000089924322010312-breitmeyer-james-b-2022-03-07 ZOGENIX, INC. 07 Mar 2022 7 $0 4 Director 09 Mar 2022, 18:16
/report/000120919122005556-breitmeyer-james-b-2022-01-27 Oncternal Therapeutics, Inc. 27 Jan 2022 1 +$42,080 4 Chief Executive Officer, Director 31 Jan 2022, 15:00
/report/000120919122004594-breitmeyer-james-b-2022-01-20 Oncternal Therapeutics, Inc. 20 Jan 2022 2 $0 4 Chief Executive Officer, Director 24 Jan 2022, 15:14
/report/000120919122001974-breitmeyer-james-b-2022-01-03 Oncternal Therapeutics, Inc. 03 Jan 2022 2 $0 4 Chief Executive Officer, Director 05 Jan 2022, 18:00
/report/000120919121043069-breitmeyer-james-b-2021-06-22 OTONOMY, INC. 22 Jun 2021 1 $0 4 Director 24 Jun 2021, 17:00
/report/000137515121000066-breitmeyer-james-b-2021-05-27 ZOGENIX, INC. 27 May 2021 1 $0 4 Director 28 May 2021, 20:03